Skip to content

Treatment of Infertility by Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchyma Stem Cells

Clinical Study of the Treatment of Infertility Caused by Recurrent Intrauterine Adhesions by Collagen Scaffold Loaded With Umbilical Cord -Derived Mesenchymal Stem Cells (UC-MSCs)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02313415
Enrollment
26
Registered
2014-12-10
Start date
2014-11-28
Completion date
2017-08-31
Last updated
2017-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility, Intrauterine Adhesions

Brief summary

Study of the treatment of infertility caused by recurrent intrauterine adhesions (IUA) by collagen scaffold loaded with umbilical cord derived mesenchymal stem cells (UC-MSCs) to provide clinical evidence of safety and effectiveness for the treatment of uterine infertility.

Detailed description

Infertility is defined as a women fails to become pregnant after having a normal sex life for two years without contraception. There is limited treatment to the infertility caused by severe IUA especially recurrent IUA after adhesiolysis which hinders embryos implantation. The existing drugs, physical or surgical treatments had no significant effects to severe recurrent intrauterine adhesions. Collagen is the main component of the extracellular matrix with good biocompatibility, UC-MSCs have been used in the clinical treatment of diseases, and achieved good results. In this study, collagen scaffold and umbilical cord blood-derived mesenchymal stem cells are combined, and they showed good biological safety.

Interventions

Before considering whether patients meet the inclusion criteria, they are diagnosed as intrauterine adhesions with at least one unsuccessful hysteroscopic surgery. And after that there will be history taking, physical examination, ultrasound examination and hysteroscopy examination. If they agree to participate, they will receive separation of adhesions by hysteroscopy surgery and endometrial biopsies, then a collagen scaffold loaded with UC-MSCs will be transplanted into the uterine cavity. The procedure was performed after taking 6 mg/day × 10 days Progynova, continuous administration of the same dosage Progynova for 30 days and 60mg of progesterone were injected on the 30th day post-operation. Postoperative observation including ultrasound examination once a month for 3 times and hysteroscopy after 3 months. The doctor will select an appropriate time for pregnancy and follow-up including requiring patients to do some unscheduled visits.

Sponsors

Institute of genetic development, Chinese Academy of Sciences
CollaboratorUNKNOWN
Institute of Zoology, Chinese Academy of Sciences
CollaboratorOTHER_GOV
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

treatment of infertility caused by recurrent intrauterine adhesions by collagen scaffold loaded with UC-MSCs

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Secondary infertility or failure of embryo transfer caused by recurrent intrauterine adhesions who desired to be pregnant * Hysteroscopy examination confirmed intrauterine adhesions * Sign a consent form * Follow the test plan and follow-up process

Exclusion criteria

* have hysteroscopic contraindications * Chromosome karyotype abnormalities * Congenital uterine malformations * Severe adenomyosis * Contraindications to estradiol treatment * Medical history of pelvic tumors or receiving pelvic radiotherapy

Design outcomes

Primary

MeasureTime frameDescription
live birth rate30 monthsA baby born alive after 20 weeks gestation was classified as a live birth.

Secondary

MeasureTime frameDescription
ongoing pregnant rate30 monthsThe presence of at least one fetus with heart pulsation on ultrasound beyond 8 weeks
Reduction of intrauterine adhesion3 months post-surgeryHysteroscopic inspection to verify degree of adhesion
The change of endometrial thicknessup to 3 monthsMeasure the endometrial thickness during late proliferating phase by ultrasound

Other

MeasureTime frameDescription
The change of menstrual blood volumebaseline and 1 monthUnderstanding the menstrual blood volume after surgery comparing with pre-operation.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026